Pressebereich

Actions

140521 PR VI BIOFLOW II study EN

Actions

Small Vessel BIOFLOW-II Subgroup Analyses Demonstrate Top Performance of BIOTRONIK Orsiro

Industry’s First Hybrid Drug-Eluting Stent Shown to be Effective in Patients with Small Vessel Disease






Please contact us if you require further information

${loading}